Quartz Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$825K Buy
688
+62
+10% +$63.3K 0.27% 77
2026
Q1
$576K Sell
626
-7
-1% -$7.1K 0.22% 85
2025
Q4
$680K Sell
633
-472
-43% -$451K 0.25% 77
2025
Q3
$843K Buy
1,105
+68
+7% +$50.6K 0.31% 69
2025
Q2
$808K Buy
1,037
+408
+65% +$317K 0.37% 59
2025
Q1
$520K Sell
629
-135
-18% -$112K 0.32% 79
2024
Q4
$590K Buy
764
+23
+3% +$19K 0.36% 74
2024
Q3
$656K Buy
+741
New +$666K 0.41% 65

Other funds holding LLY

Quartz Partners's LLY Position: Q2 2026 in Review

Quartz Partners increased its Eli Lilly (LLY) stake by 9.9% in Q2 2026, buying an estimated $63.3K and bringing the position to 688 shares worth $825K. The position accounts for 0.27% of the portfolio, ranked #77.

Quartz Partners first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. The position peaked at $843K in Q3 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Quartz Partners held 688 shares of Eli Lilly worth $825K as of Q2 2026.
  • Quartz Partners bought 62 Eli Lilly shares in Q2 2026, an estimated $63.3K.
  • Eli Lilly made up 0.27% of Quartz Partners's portfolio in Q2 2026, its #77 holding.
  • Quartz Partners first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • Quartz Partners's Eli Lilly position peaked at $843K in Q3 2025.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Quartz Partners's 13F filing for Q2 2026, filed 10 Aug 2026.